<DOC>
	<DOCNO>NCT02341274</DOCNO>
	<brief_summary>Amorphous solid dispersion ( ASD ) formulation increasingly use pharmaceutical industry develop poorly water-soluble drug effective oral dosage form . Examples include antifungal drug itraconazole , HIV protease inhibitor combination , lopinavir/ritonavir immunosuppressive , tacrolimus . There potential significant variation bioavailability ASD thus heighten concern regard therapeutic efficacy generic version poorly water-soluble compound become approve . The variation bioavailability expect limited understanding precise physical chemistry drug polymer amorphous solid dispersion formulation .</brief_summary>
	<brief_title>Effects Altered Formulation Bioequivalence Tacrolimus Healthy Female Male Volunteeers</brief_title>
	<detailed_description>The specific aim conduct randomize , single dose , four-treatment , four-period cross-over bioequivalence ( BE ) study 24 healthy normal adult volunteer ( male non-gravid female ) evaluate vivo performance fresh age brand name generic amorphous solid dispersion ( ASD ) preparation tacrolimus . The pharmacokinetics tacrolimus fresh Prograf® age Prograf® , fresh generic tacrolimus capsule age generic tacrolimus capsule determine compare healthy volunteer . The hypothesis test tacrolimus amorphous solid dispersion formulation partially crystalize upon treatment control heat humidity demonstrate low absorption ( lower relative bioavailability ) compare fresh product . Moreover , expectation heat- humidity-stressed generic formulation robust crystallization stress brand name drug demonstrate decrease vivo performance loss bioequivalence . A total 24 healthy female male volunteer ( age 18 49 year old ) recruit participate study . Volunteers determine free significant medical condition assess medical history , physical examination , blood urine test . Volunteers randomly allocate receive one four treatment sequence group , occasion , receive one following : Fresh Prograf ( RLD ) , fresh generic tacrolimus , 10-30 % crystallize generic ( Low Crystal ) , 40-60 % crystallize generic ( High Crystal ) tacrolimus . There minimum 2-week washout treatment . On occasion , healthy volunteer administer tacrolimus , 5 mg , single capsule orally empty stomach approximately 240 mL water . Blood sample collect indwell venous catheter ( ∼10 ml ) 0.5 , 1 , 2 , 3 , 4 , 6 , 8 , 12 24 hour dose . Subjects regularly monitor time . The volunteer allow eat normal lunch 3 hour take tacrolimus dose . The primary endpoint maximum blood concentration ( Cmax ) area curve ( AUC ) zero 24 hour AUC extrapolate zero infinity tacrolimus bioequivalence study recommend FDA guidance industry . We compute AUC ( zero 24 hour ) last time point measurable concentration use linear trapezoidal rule AUC time zero time infinity extrapolation compute quotient last measurable concentration terminal slope log concentration vs. time curve . In addition , report half-life tacrolimus estimate terminal slope concentration vs. time plot determine linear least square regression . The peak blood tacrolimus concentration ( Cmax , ) time Cmax ( Tmax , ) determine visual inspection individual subject concentration-time curve . A treatment consider bioequivalent geometric least square mean ratio 90 % confidence interval Cmax AUC fall 0.80 1.25 fresh Prograf® .</detailed_description>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Methamphetamine</mesh_term>
	<criteria>Male female subject 18 49 year old . Healthy individual without significant medical condition . Nonsmoker individual willing refrain smoking use tobacco marijuana l one month prior completion study . The entire study volunteer last minimum 42 day . Ability commit time request study . Ability swallow capsule . Underweight ( weigh less 52 kg 114 lb . ) overweight ( body mass index ( BMI ) great 32 ) . History current alcohol drug abuse ( 3 alcoholic drink per day regular basis ) . History current significant health condition heart , liver , kidney . History current psychiatric illness depression , anxiety , nervousness . History current gastrointestinal disorder persistent diarrhea malabsorption would interfere absorption orally administer drug . Individuals serious infection within last month . Donation blood within past two month . Blood hemoglobin le 12.5 mg/dL . Individuals regularly take prescription , overthecounter , herbal dietary supplement , alternative medication , hormonal agent ( i.e . oral contraceptive , intrauterine device hormone ) . Females positive pregnancy test . Breastfeeding . Females childbearing potential unable unwilling either practice abstinence use two nonhormonal form birth control ( e.g . condom , contraceptive foam ) study completion , take total 30 day . Participation research study use investigational drug last two month . An employee student supervision investigator study . Individuals state good understanding study include risk requirement ; unable follow rule study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Tacrolimus</keyword>
	<keyword>Drug Formulation</keyword>
	<keyword>Absorption</keyword>
	<keyword>Bioavailability</keyword>
	<keyword>Healthy Volunteer</keyword>
</DOC>